Yuan Zhi Analyst PerformanceManaging Director at B. Riley FinancialYuan Zhi is a stock analyst at B. Riley Financial focused in the medical sector, covering 10 publicly traded companies. Over the past year, Yuan Zhi has issued 10 stock ratings, including strong buy and buy recommendations. While full access to Yuan Zhi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yuan Zhi's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings18 Last 1 YearsBuy Recommendations100.00% 18 Buy RatingsCompanies Covered10 Unique Companies Ratings Distribution18RatingsDistribution of strong buy, buy, hold, and sell ratings by Yuan Zhi.RatingPercentageCount Strong Buy11.1%2 ratings Buy88.9%16 ratings Hold0.0%0 ratings Sell0.0%0 ratingsOut of 18 total stock ratings issued by Yuan Zhi at B. Riley Financial, the majority (88.9%) have been Buy recommendations, followed by 11.1% Strong Buy.Best & Worst CallsBest Call0000.0%HYPRMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CATXJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ80.0% of companies on NASDAQ8 companiesNYSEAMERICAN10.0% of companies on NYSEAMERICAN1 companyNYSE10.0% of companies on NYSE1 companyYuan Zhi, an analyst at B. Riley Financial, currently covers 10 companies listed on NASDAQ, NYSEAMERICAN and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical7 companies70.0%Manufacturing1 company10.0%Transportation1 company10.0%Business Services1 company10.0%Yuan Zhi of B. Riley Financial specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Transportation companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE2 companies20.0%MED - DRUGS1 company10.0%PHARMACEUTICAL PREPARATIONS1 company10.0%AIR TRANSPORTATION1 company10.0%SURGICAL & MEDICAL INSTRUMENTS1 company10.0%MEDICAL SERVICES1 company10.0%MED - OUTP/HM CRE1 company10.0%TECHNOLOGY SERVICES1 company10.0%MED INSTRUMENTS1 company10.0% Yuan Zhi's Ratings History at B. Riley Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLYELLyell Immunopharma7/22/2026Initiated Coverage$13.11$44.00Buy$0.0000.00% ROIWHWKWhitehawk Therapeutics6/25/2026Initiated Coverage$4.39$10.00Buy$0.0000.00% ROISRTAStrata Critical Medical3/24/2026Upgrade$4.38Strong-Buy$0.0000.00% ROICATXPerspective Therapeutics3/18/2026Boost Price Target$4.91$13.00Buy$0.0000.00% ROITOIOncology Institute3/13/2026Boost Price Target$2.85$8.00Buy$0.0000.00% ROIRADXRadiopharm Theranostics12/16/2025Reiterated Rating$6.40$16.00Buy$0.0000.00% ROIRDNTRadNet12/1/2025Boost Price Target$82.85$87.00Buy$0.0000.00% ROIRADXRadiopharm Theranostics11/26/2025Lower Price Target$4.62$13.00Buy$0.0000.00% ROITNGXTango Therapeutics11/18/2025Boost Price Target$7.97$14.00Buy$0.0000.00% ROICATXPerspective Therapeutics11/18/2025Lower Price Target$2.09$11.00Buy$0.0000.00% ROIMIRMirion Technologies7/23/2025Reiterated Rating$21.55$22.00Buy$00.0000.00% ROITOIOncology Institute7/16/2025Initiated Coverage$2.97$6.00Buy$0.0000.00% ROITOIOncology Institute7/15/2025Upgrade$3.23Strong-Buy$0.0000.00% ROICATXPerspective Therapeutics6/23/2025Reiterated Rating$3.99$12.00Buy$0.0000.00% ROIRDNTRadNet6/13/2025Initiated Coverage$56.58$69.00Buy$00.0000.00% ROIHYPRHyperfine5/15/2025Lower Price Target$0.60$1.00Buy$0.0000.00% ROIMIRMirion Technologies4/16/2025Lower Price Target$13.69$17.00Buy$00.0000.00% ROIHYPRHyperfine3/20/2025Lower Price Target$0.85$1.20Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsDeutsche Bank AktiengesellschaftStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
